Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
This intro covers which coins are blue chip crypto and why they’re favored by investors. We outline criteria, track records, and what to watch before investing.
21,488 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
CrossCountry Mortgage enters the race to acquire Two Harbors, joining a competing all cash bid and heightening a batt...
The VIX nears the 30 threshold as geopolitical tensions and energy prices spike risk. Markets brace for a choppier we...
A leading global shipping ETF is drawing attention for its current yield and rebound potential as sea lanes remain vo...
If you’re worried about stock market volatility, defensive dividend stocks can help. This guide covers smart picks, s...
Morgan Stanley cuts Li Auto to a $22 price target while maintaining an upbeat view on margin recovery tied to the L9 ...
CrowdStrike stock absolutely hammered this week, yet the dip isn’t a clear buy signal. I break down the risks, the gr...
Disney reports stronger-than-expected Q2 2026 results, lifting the stock 8% in early trading as streaming and parks r...
As AI reshapes markets in 2026, savvy growth investors focus on durable franchises, strong cash flow, and scalable AI...
Investors are watching Criteo's early 2026 results to gauge the ad-tech pioneer's progress in privacy-friendly target...
Bank of America signals a noticeable pullback in card use across its customers, adding to a growing picture of cautio...
Two tech giants just crossed the earnings finish line, and the market reacted differently. Read how Amazon and Micros...